Insider · CIK 0001617306
Marc J Yoskowitz
Files at MNKTQ (Mallinckrodt plc), MREO (Mereo BioPharma Group plc). First filing -, latest -.
In brief
Marc J Yoskowitz files SEC Form 4 as director at MNKTQ (Mallinckrodt plc), and also at MREO (Mereo BioPharma Group plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Marc J Yoskowitz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | MNKTQ Mallinckrodt plc | AGrant or award Restricted Stock Unitsderivative | +4,406 | $0.00 | $0 | 9,718 | Jul 17, 2026 |
| Jun 2, 2026 | MNKTQ Mallinckrodt plc | MOption exercise Ordinary Shares | +3,579 | - | - | 4,366 | Jun 4, 2026 |
| Jun 2, 2026 | MNKTQ Mallinckrodt plc | FTax withholding Ordinary Shares | -825 | - | - | 3,541 | Jun 4, 2026 |
| Jun 2, 2026 | MNKTQ Mallinckrodt plc | DDisposition to issuer Restricted Stock Unitsderivative | -2,930 | - | - | 8,891 | Jun 4, 2026 |
| Jun 2, 2026 | MNKTQ Mallinckrodt plc | MOption exercise Restricted Stock Unitsderivative | -3,579 | $0.00 | $0 | 5,312 | Jun 4, 2026 |
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | AGrant or award Share Options (Right to buy)derivative | +66,000 | $0.00 | $0 | 66,000 | Feb 27, 2026 |
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | AGrant or award Deferred Restricted Stock Unitsderivative | +96,163 | - | - | 96,163 | Feb 27, 2026 |
| Feb 23, 2026 | MNKTQ Mallinckrodt plc | AGrant or award Restricted Stock Unitsderivative | +5,312 | $0.00 | $0 | 11,821 | Feb 25, 2026 |
| Oct 20, 2025 | MNKTQ Mallinckrodt plc | AGrant or award Restricted Stock Unitsderivative | +1,354 | $0.00 | $0 | 5,416 | Oct 20, 2025 |
| Aug 14, 2025 | MNKTQ Mallinckrodt plc | AGrant or award Restricted Stock Unitsderivative | +4,062 | $0.00 | $0 | 4,062 | Aug 18, 2025 |
Questions about Marc J Yoskowitz
Answered from the filings on this page, as of the latest one.
Is Marc J Yoskowitz buying or selling?
Marc J Yoskowitz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Marc J Yoskowitz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marc J Yoskowitz has 0.
Where does Marc J Yoskowitz file Form 4?
Marc J Yoskowitz has filed Form 4 at MNKTQ (Mallinckrodt plc); MREO (Mereo BioPharma Group plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.